机译:ADAMTS-13活性可预测重组人可溶性血栓调节蛋白? sup>治疗的血液系统恶性肿瘤中弥散性血管内凝血的结果
Division of Hematology and Oncology Department of Medicine Kyoto Prefectural University of Medicine Kyoto Japan;
Department of Hematology Kyoto Second Red Cross Hospital Kyoto Japan;
Department of Hematology Matsushita Memorial Hospital Osaka Japan;
Department of Hematology Aiseikai-Yamashina Hospital Kyoto Japan;
Department of Hematology Kyoto First Red Cross Hospital Kyoto Japan;
Department of Hematology Kyoto Social Insurance Hospital Kyoto Japan;
机译:ADAMTS-13活性可预测重组人可溶性血栓调节蛋白治疗的血液系统恶性肿瘤中弥散性血管内凝血的结果
机译:弥散性血管内凝结的小儿造血性恶性肿瘤患者重组人可溶性血栓素α的重组人群代谢动力学。
机译:弥散性血管内凝结的小儿造血性恶性肿瘤患者重组人可溶性血栓素α的重组人群代谢动力学。
机译:重组人可溶性血栓调节蛋白治疗实体瘤相关性弥散性血管内凝血综合征的临床疗效回顾性分析
机译:Adamts-13活性可以预测重组人可溶性血栓调节素治疗的血液学恶性肿瘤中散发血管内凝血的结果